| Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies S Segerer, PJ Nelson, D SCHLO Journal of the American Society of Nephrology 11 (1), 152-176, 2000 | 784 | 2000 |
| RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium P Von Hundelshausen, KSC Weber, Y Huo, AEI Proudfoot, PJ Nelson, ... Circulation 103 (13), 1772-1777, 2001 | 767 | 2001 |
| Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection M Mack, A Kleinschmidt, H Brühl, C Klier, PJ Nelson, J Cihak, J Plachý, ... Nature medicine 6 (7), 769-775, 2000 | 762 | 2000 |
| Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity M Mack, B Luckow, PJ Nelson, J Cihak, G Simmons, PR Clapham, ... The Journal of experimental medicine 187 (8), 1215-1224, 1998 | 529 | 1998 |
| Modular activation of nuclear factor-κB transcriptional programs in human diabetic nephropathy H Schmid, A Boucherot, Y Yasuda, A Henger, B Brunner, F Eichinger, ... Diabetes 55 (11), 2993-3003, 2006 | 476 | 2006 |
| Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid C Schläger, H Körner, M Krueger, S Vidoli, M Haberl, D Mielke, E Brylla, ... Nature 530 (7590), 349-353, 2016 | 379 | 2016 |
| Expression of CCR2 by endothelial cells: implications for MCP-1 mediated wound injury repair and in vivo inflammatory activation of endothelium KSC Weber, PJ Nelson, HJ Gröne, C Weber Arteriosclerosis, thrombosis, and vascular biology 19 (9), 2085-2093, 1999 | 356 | 1999 |
| RANTES chemokine expression in cell-mediated transplant rejection of the kidney. J Pattison, PJ Nelson, P Huie, I Von Leuttichau, G Farshid, RK Sibley, ... Lancet (London, England) 343 (8891), 209-211, 1994 | 345 | 1994 |
| Genomic organization and transcriptional regulation of the RANTES chemokine gene. PJ Nelson, HT Kim, WC Manning, TJ Goralski, AM Krensky Journal of immunology (Baltimore, Md.: 1950) 151 (5), 2601-2612, 1993 | 340 | 1993 |
| Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and TH1-like/CD45RO+T cells C Weber, KSC Weber, C Klier, S Gu, R Wank, R Horuk, PJ Nelson Blood, The Journal of the American Society of Hematology 97 (4), 1144-1146, 2001 | 331 | 2001 |
| Met‐RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment HJ Gröne, C Weber, KSC Weber, EF Gröne, T Rabelink, CM Klier, ... The FASEB journal 13 (11), 1371-1383, 1999 | 313 | 1999 |
| Chemokines, chemokine receptors, and allograft rejection PJ Nelson, AM Krensky Immunity 14 (4), 377-386, 2001 | 298 | 2001 |
| A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation HJ Anders, V Vielhauer, M Frink, Y Linde, CD Cohen, SM Blattner, ... The Journal of clinical investigation 109 (2), 251-259, 2002 | 297 | 2002 |
| Human adult CD34-progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4 I Von Luttichau, M Notohamiprodjo, A Wechselberger, C Peters, A Henger, ... Stem Cells Dev 14 (3), 329-336, 2005 | 274 | 2005 |
| Chemokines and renal disease D Schlöndorff, PJ Nelson, B Luckow, B Banas Kidney international 51 (3), 610-621, 1997 | 230 | 1997 |
| Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma C Zischek, H Niess, I Ischenko, C Conrad, R Huss, KW Jauch, PJ Nelson, ... Annals of surgery 250 (5), 747-753, 2009 | 226 | 2009 |
| Lipid metabolism in cancer progression and therapeutic strategies Y Fu, T Zou, X Shen, PJ Nelson, J Li, C Wu, J Yang, Y Zheng, C Bruns, ... MedComm 2 (1), 27-59, 2021 | 217 | 2021 |
| Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. M Xia, D Leppert, SL Hauser, SP Sreedharan, PJ Nelson, AM Krensky, ... Journal of immunology (Baltimore, Md.: 1950) 156 (1), 160-167, 1996 | 210 | 1996 |
| Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo C Conrad, H Niess, R Huss, S Huber, I Von Luettichau, PJ Nelson, HC Ott, ... Circulation 119 (2), 281-289, 2009 | 205 | 2009 |
| Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma JS Schleypen, N Baur, R Kammerer, PJ Nelson, K Rohrmann, EF Gröne, ... Clinical cancer research 12 (3), 718-725, 2006 | 181 | 2006 |
Matthias KretzlerProfessor of Internal Medicine, University of MichiganEmail verificata su umich.edu
